• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
    • Dynamic Chiropractic
      • Newspaper
      • Subscription
    • The American Chiropractor
      • Magazine
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Sponsored Content
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
    • Coronavirus (COVID-19)
  • Resource Centers
  • Products & Services
    • Buyers Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students

Study: probiotic supplementation reduces atopic dermatitis

Chiropractic Economics June 15, 2010

June 15, 2010 — A clinical study using probiotic mixture containing L. acidophilus DDS-1 and B. lactis UABLA-12 demonstrated significant clinical improvement in preschool children with atopic dermatitis (AD).

A clinical study to determine the impact of a mixture of L. acidophilus DDS-1 and B. lactis UABLA-12 on 90 preschool children (ages 1-3 years) with moderate to severe AD vs. a placebo demonstrated a 33.7 percent decrease in SCORAD (scoring of atopic dermatitis) versus 19.4 percent in the placebo group.

Other outcome measures included IDQOL (infant dermatitis quality of life 33 percent increase in probiotic group vs. 19 percent in placebo) and DFI (dermatitis family impact 34.4 percent in probiotic group vs. 23.8 percent in placebo).

This paper will be presented at the New York Academy of Sciences symposium, Probiotics: From Bench to Market, on June 11, 2010. The conference is designed to bring together scientists from industry, academia and government to discuss the emerging science of mechanisms behind the possible benefits of probiotic microorganisms in promoting human health and combating disease.

The study on probiotic supplementation on preschool children with AD was conducted by Dr. SV Gerasimov, MD, PhD from the Department of Pediatrics, Lviv National Medical University, Lviv, Ukraine. AD is a common inflammatory skin disorder that affects 15.6 percent of the population in Europe and 17.2 percent and is steadily increasing in frequency. The disease often occurs in early childhood and persists into adult life (over 60 percent of patients).

Current treatments include skin hydration, emollients, avoidance of allergens and irritants, use of antihistamines or topical corticosteroids. These treatments may alleviate symptoms but are often ineffective. The therapeutic use of probiotics has attracted considerable attention after publication of the hygiene hypothesis (Strachan DP. Hay fever, hygiene and household size. BMJ 1989;299:1259-60.)

Several clinical studies have demonstrated mild to complete resolution of AD following treatment with probiotics while others have suggested the effect is limited to select children with atopy.

This study was designed to determine the clinical efficacy of a new probiotic preparation and to determine the impact on peripheral lymphocytes.

The study involved 90 preschool children randomly divided into two groups to receive either the probiotic or the placebo. Parents administered the doses twice per day to provide a total of 10 billion CFU/gram of a combination of Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABLA-12 with FOS. The primary outcome measure was percent change in SCORAD index at week 8.

Secondary outcomes were changes in IDQOL, DFI at weeks 2, 4, 8, frequency and amount of topical corticosterioid used and absolute number and percent of peripheral blood lymphocyte subsets at week 8. Patients displayed a progressive decline in SCORAD indexes reaching significant difference at week 4 in both groups. However children receiving probiotics experienced a more rapid decline (summarized in table)

Treatment Group

Decrease in SCORAD

Week 2

Decrease in SCORAD

Week 4

Decrease in SCORAD

Week 8

Probiotic

-4.7

-8.7

-14.2

Placebo

-2.5

-5.1

-7.8

Patients with active AD had a reduced percentage of CD3 and CD8 peripheral lymphocytes and increased CD4 and CD25 counts. Hypothetically, the recovery from AD due to use of probiotics may be accompanied by normalization of CD3, CD4, CD8 and CD25 numbers. The study showed a correlation between reduction in CD4 and CD25 percent/absolute number and SCORAD values at week 8 in the probiotic group.

The use of a probiotic mixture containing L. acidophilus DDS-1, B. lactis UABLA-12 and fructooligosaccharide was associated with significant clinical improvement in children with AD, and corresponding lymphocyte subset changes in peripheral blood. The efficacy of probiotic therapy in adults with AD will need more investigation.

Source: UAS Laboratories, www.uaslabs.com

Related Posts

  • [Infographic] Every Shoe Tells A Story[Infographic] Every Shoe Tells A Story
  • Cold therapy benefits and the science of coolCold therapy benefits and the science of cool
  • The Vitality Depot receives vendor of the year award from American Chiropractic AssociationThe Vitality Depot receives vendor of the year award from American Chiropractic Association
  • Becoming THE chiropractor in town: part IIIBecoming THE chiropractor in town: part III
  • Dynamic Chiropractic Newspaper | Information About the PublicationDynamic Chiropractic Newspaper | Information About the Publication
  • Getting up to speed with social mediaGetting up to speed with social media

Filed Under: Industry News, News

Current Issue

CE issue 2 cover

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

Compare Subscriptions

Dynamic Chiropractic

The American Chiropractor

3948 3rd Street South #279,

Jacksonville Beach, FL 32250

Phone 904.285.6020

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • F4CP partners with 5 chiropractic colleges for mobile marketing campaign
  • Doctors of Chiropractic in the News: Community service and Olympic-level care
  • Foundation for Chiropractic Progress’ Podcast Wins Gold in the AVA Digital Awards
    Foundation for Chiropractic logo